Specialty code 183500000X · Roseville, CA
NPI
1821574518
Since 2018
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1600 Eureka Rd
Roseville, CA, 95661
Phone (916) 746-3755
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$486K
2,354 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Thien Q Nguyen prescribed most often to Medicare patients was Ozempic (Semaglutide), with 300 prescriptions and refills. In total Thien Q Nguyen wrote 2,354 Medicare prescriptions that cost $486K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 300 | 314 | 48 | $222K |
| Metformin Hcl Er Metformin Hcl | 202 | 672 | 76 | $2,026 |
| Atorvastatin Calcium Generic | 174 | 580 | 68 | $2,105 |
| Metformin Hcl Generic | 172 | 564 | 61 | $2,374 |
| Glipizide Generic | 160 | 533 | 60 | $2,348 |
| Glipizide Er Glipizide | 144 | 472 | 59 | $4,424 |
| Humulin N Insulin Nph Human Isophane | 142 | 437 | 57 | $30K |
| Jardiance Empagliflozin | 113 | 371 | 44 | $70K |
| Insulin Glargine-Yfgn Generic | 82 | 221 | 39 | $12K |
| Lisinopril Generic | 77 | 256 | 29 | $980 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 70 | 205 | 34 | $1,995 |
| Amlodipine Besylate Generic | 58 | 193 | 22 | $687 |
| Humulin R Insulin Regular, Human | 54 | 163 | 23 | $10K |
| Losartan Potassium Generic | 51 | 170 | 19 | $709 |
| Simvastatin Generic | 43 | 143 | 14 | $502 |
Brand drugs: 861 claims; generic drugs: 1,295 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Thien Q Nguyen were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.